CURAMIR THERAPEUTICS
Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability. Its novel approach addresses current challenges associated with both chemoresistance in cancer and effective systemic delivery of miRNA mimics.
CURAMIR THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.curamirtherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
Delos Capital
Delos Capital investment in Series A - Curamir Therapeutics
Official Site Inspections
http://www.curamirtherapeutics.com
- Host name: 104.17.54.64
- IP address: 104.17.54.64
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
